HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A study of the dermo-epidermal junction in dystrophic epidermolysis bullosa using the periodic acid-thiosemicarbazide-silver proteinate technique.

Abstract
Dermo-epidermal separation in dystrophic epidermolysis bullosa (DEB) is thought to results from an abnormality of anchoring fibrils which, in normal skin, are stained selectively by the periodic acid-thiosemicarbazide-silver proteinate technique. This method was applied to non-lesional skin from four patients with generalized recessive DEB, five with localized recessive DEB and one with dominant DEB. No anchoring fibrils were present in the subjects with generalized recessive DEB, but they were morphologically normal in the case of dominant DEB and in three patients with mild localized recessive DEB. Two patients with a more severe form of localized recessive DEB possessed attenuated anchoring fibrils which lacked the normal banding of the mid-portion. The lamina densa, normally unlabelled, was consistently stained in patients with generalized recessive DEB, suggesting a biochemical abnormality of this structure.
AuthorsJ Nanchahal, M J Tidman
JournalThe British journal of dermatology (Br J Dermatol) Vol. 113 Issue 4 Pg. 397-404 (Oct 1985) ISSN: 0007-0963 [Print] England
PMID2415149 (Publication Type: Journal Article)
Chemical References
  • Silver Proteins
  • Thiosemicarbazones
  • Periodic Acid
Topics
  • Adolescent
  • Adult
  • Child
  • Epidermis (pathology)
  • Epidermolysis Bullosa (genetics, pathology)
  • Female
  • Genes, Dominant
  • Genes, Recessive
  • Humans
  • Male
  • Middle Aged
  • Periodic Acid
  • Silver Proteins
  • Skin (pathology)
  • Staining and Labeling (methods)
  • Thiosemicarbazones

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: